Clinical Trial Shines Light on Sleep Disorders in Blind Patients

Last month, The Lancet published an article describing a recent phase III clinical trial in totally blind patients. The study evaluated the efficacy of a new medical intervention called tasimelteon for non-24-hour sleep-wake disorders.1 The science behind these conditions is simple. Circadian rhythm sleep-wake disorders result from discordance between an individual’s environment and the sleep-wake […]